Clinical application of intra-aortic balloon pump in patients with serious cardiovascular diseases.
10.3969/j.issn.1672-7347.2012.04.014
- Author:
Qiong XIE
1
;
Ying GUO
;
Hongwei PAN
;
Ming ZHOU
;
Ping ZHANG
Author Information
1. Department of Cardiology, Hunan Provincial People's Hospital, Changsha 410005, China.
- Publication Type:Journal Article
- MeSH:
Aged;
Cardiomyopathies;
surgery;
therapy;
Critical Illness;
Female;
Humans;
Intra-Aortic Balloon Pumping;
methods;
Male;
Middle Aged;
Myocardial Infarction;
surgery;
therapy;
Retrospective Studies
- From:
Journal of Central South University(Medical Sciences)
2012;37(4):400-404
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To estimate the therapeutic effect and safety of intra-aortic balloon pumps (IABP) in patients with serious cardiovascular diseases.
METHODS:We retrospectively analyzed the clinical data of 68 patients with serious cardiovascular diseases, who were enrolled in Hunan Provincial People's Hospital between 2009 and 2011. All patients received IABP support. The systolic blood pressure, diastolic blood pressure,heart rate, N-terminal precursor of brain natriuretic peptide (NT-proBNP), and renal function of all patients were determined before and after the IABP. Cardiac events and mortality were observed after IABP support.
RESULTS:The disease in 51 patients improved after IABP support. The systolic blood pressure, diastolic blood pressure,heart rate, and NT-proBNP were significantly lower than those before the IABP. Thirty-seven patients with acute myocardial infarction successfully completed percutaneous coronary intervention surgery after the IABP support. Five patients had IABP-related complications, but no serious complication occurred.
CONCLUSION:IABP is an effective and safe procedure for critical cardiovascular patients. IABP should be applied early for the patients with appropriate indications.
